SCHEMBL2487420

SCHEMBL2487420

C=CCC(c1cc(C(F)(F)F)cc(C(F)(F)F)c1)N(C)C(=O)N1CCNCC1c1ccc(F)cc1C

nearest known ligand 0.76

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 20/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4028313 0.87 TACR1 (0.59) TACR1
Vestipitant SCHEMBL2487615 0.86 TACR1 (1.00) TACR1
Vestipitant SCHEMBL14336089 0.86 TACR1 (1.00) TACR1
Vestipitant SCHEMBL2485871 0.86 TACR1 (1.00) TACR1
Vestipitant SCHEMBL29447787 0.86 TACR1 (1.00) TACR1
SCHEMBL2487012 0.86 TACR1 (0.85) TACR1
SCHEMBL19442685 0.85 TACR1 (0.83) TACR1
Vestipitant SCHEMBL14335426 0.84 TACR1 (0.90) TACR1
Vestipitant SCHEMBL14335424 0.84 TACR1 (0.90) TACR1
SCHEMBL2489228 0.83 TACR1 (0.81) TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2117535-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS GLAXO GROUP LTD (GB) 2011-10-26 EP disclosed
EP-2117562-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS GLAXO GROUP LTD (GB) 2011-10-26 EP disclosed